Sex-Specific GLP-1 Brain Map Could Explain Weight-Loss Drug Differences

Researchers used RNAscope to build the first sex-specific atlas of GLP-1 expression in the mouse brain, mapping GLP-1 across 25 brain nuclei in three female and three male mice. They found notable sex differences: females have higher GLP-1 density in hindbrain appetite regions (ROb, SolV, SolM), while males show higher GLP-1 in the olfactory bulb, with some regions showing female-only (ventral tegmental area) or male-only (lateral hypothalamus) expression. The atlas helps explain why women often lose more weight on GLP-1 drugs like semaglutide and suggests potential sex-specific avenues for treating addiction, depression, and cognitive decline, though limitations include the small sample size and the fact that transcript presence does not prove peptide release or function.